IQVIA vs Premier Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/iqvia/premier-research

Category	IQVIA	Premier Research
Listed site	cro	cro
Summary	IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes.	Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Services	Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Regulatory Affairs Pharmacovigilance & Drug Safety Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy Central Laboratory Services China NMPA Regulatory Strategy Biomarker Assays Bioanalysis Clinical Imaging Core Lab Translational Research Immunogenicity Assays (ADA / NAb) Bioinformatics & Data Science Cardiovascular & Metabolic Specialty Services CNS Specialty Services Oncology Specialty Services Immunology & Inflammation Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Central Laboratory Services Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Translational Research GLP Toxicology Safety Pharmacology In Vitro ADME / DMPK In Vitro Pharmacology Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Device & Combination Product Services
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine Peptide
Indications	Cardiovascular Neurology Dermatology Ophthalmology Gastroenterology Nephrology Respiratory Infectious Disease Oncology Rare Disease Immunology Metabolic Psychiatry Women's Health	Oncology Immunology Neurology Infectious Disease Rare Disease Dermatology Women's Health
Locations	Global presence, Multiple Global presence, Multiple regions Argentina, Buenos Aires, Buenos Aires, Argentina	Headquarters, Morrisville, NC, United States Southbank, Southbank, VIC, Australia Sofia, Sofia, Bulgaria Toronto, Mississauga, ON, Canada Prague, Praha, Czech Republic Paris, Paris, France Darmstadt, Darmstadt, Germany Budapest, Budapest, Hungary Bengaluru, Bengaluru, India Auckland, Auckland, New Zealand Warsaw, Warszawa, Poland Bucharest, Bucharest, Romania Bratislava, Bratislava, Slovakia Seoul, Seoul, South Korea Madrid, Madrid, Spain Taipei, Taipei, Taiwan Kyiv, Kyiv, Ukraine Wokingham, Wokingham, Berkshire, United Kingdom
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.